Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.
about
New prognostic markers in neuroblastoma.Emerging drugs for neuroblastoma.Differential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients.Early detection of tumor relapse/regrowth by consecutive minimal residual disease monitoring in high-risk neuroblastoma patients.Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma.TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients
P2860
Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Minimal disease detection in p ...... non-metastatic neuroblastoma.
@en
Minimal disease detection in p ...... non-metastatic neuroblastoma.
@nl
type
label
Minimal disease detection in p ...... non-metastatic neuroblastoma.
@en
Minimal disease detection in p ...... non-metastatic neuroblastoma.
@nl
prefLabel
Minimal disease detection in p ...... non-metastatic neuroblastoma.
@en
Minimal disease detection in p ...... non-metastatic neuroblastoma.
@nl
P2093
P2860
P50
P1476
Minimal disease detection in p ...... non-metastatic neuroblastoma.
@en
P2093
Elena Grau
Rosa Noguera
Sarai Palanca
Victoria Castel
Yania Yáñez
P2860
P2888
P304
P356
10.1007/S00432-011-0997-X
P577
2011-06-25T00:00:00Z